Compartilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Hematology, Transfusion and Cell Therapy
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
10.1016/j.htct.2021.10.1056
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50
Open access
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
10.1016/j.htct.2021.10.1057
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50
Open access
A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION
Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
10.1016/j.htct.2021.10.1060
Hematol Transfus Cell Ther. 2021;43 Supl 3:S51
Open access
WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Sevda SERT EKINCI, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, Mustafa Nuri YENEREL, Meliha NALCACI, Tufan TUKEK, Sevgi KALAYOGLU BESISIK
10.1016/j.htct.2021.10.1063
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52
Open access
How to COVID pandemic changed clinical practice
Medine Yılmaz
10.1016/j.htct.2021.11.007
Hematol Transfus Cell Ther. 2021;43 Supl 3:S69
Open access
PURPURA TROPOCITOPÊNICA TROMBÓTICA POSSIVELMENTE ASSOCIADA À VACINA CONTRA COVID-19
T Gavron, MAB Beleze, FC Trigo, LC Franco
10.1016/j.htct.2021.10.045
Hematol Transfus Cell Ther. 2021;43 Supl 1:S26-7
Open access
INCIDENCE, MITIGATION, AND MANAGEMENT OF NEUROLOGIC ADVERSE EVENTS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN CARTITUDE-2
H Einsele, S Parekh, D Madduri, B Santomasso, JG Pérez-Larraya, NWV Donk, B Arnulf, M Mateos, KC Braganca, H Varsos, MJ Carrasco-Alfonso, M Akram, N Lendvai, CC Jackson, Y Olyslager, E Zudaire, C Li, D Geng, A Jakubowiak, A Cohen
10.1016/j.htct.2021.10.447
Hematol Transfus Cell Ther. 2021;43 Supl 1:S263-4
Open access
AVALIAÇÃO DA INTEGRIDADE DA BARREIRA ENDOTELIAL E SUA RELAÇÃO COM AS MANIFESTAÇÕES CLÍNICAS E LABORATORIAIS NA COVID-19
IT Borba-Junior, CRP Moraes, F Lima, MS Barbosa, JM Annichino-Bizzacchi, E Mansour, LA Velloso, FTM Costa, FA Orsi, EV Paula
10.1016/j.htct.2021.10.367
Hematol Transfus Cell Ther. 2021;43 Supl 1:S217
Open access
AVALIAÇÃO DOS NÍVEIS CIRCULANTES DE MEDIADORES DA INTEGRIDADE DA BARREIRA ENDOTELIAL NA COVID-19 E SUA RELAÇÃO COM A ATIVAÇÃO DA HEMOSTASIA
CRP Moraes, F Lima, IT Borba-Junior, MS Barbosa, SC Huber, E Mansour, JM Annichino-Bizzacchi, LA Velloso, FA Orsi, EV Paula
10.1016/j.htct.2021.10.368
Hematol Transfus Cell Ther. 2021;43 Supl 1:S217-8
Open access
MICROVESÍCULAS CIRCULANTES EM PACIENTES COM COVID-19 E SUA RELAÇÃO COM A GRAVIDADE DA DOENÇA E ATIVAÇÃO DA HEMOSTASIA
MS Barbosa, F Lima, CRP Moraes, IT Borba-Júnior, SC Huber, IP Santos, E Mansour, LA Velloso, EV Paula
10.1016/j.htct.2021.10.370
Hematol Transfus Cell Ther. 2021;43 Supl 1:S219
Open access
Conteúdo especial sobre COVID-19
- Prevalence of anti-HLA antibodies in COVID-19 convalescent plasma donors: an Indian experience
- 2 - Anuncio Acreditacao
- DOES PET/CT WITH 18F-FLUOROESTRADIOL (18F-FES) CONTRIBUTE TO THE ASSESSMENT OF BREAST CANCER COMPARED TO FLUORINE-2-D-DEOXYGLUCOSE (18F-FDG)?
- Anti-PF4 antibodies and their relationship with COVID infection
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.